ARGENTUM PHARMACEUTICALS v. NOVARTIS PHARM. CORP.

2018-2273.

956 F.3d 1374 (2020)

ARGENTUM PHARMACEUTICALS LLC, Appellant v. NOVARTIS PHARMACEUTICALS CORPORATION, Appellee.

United States Court of Appeals, Federal Circuit.

Decided: April 23, 2020.


Attorney(s) appearing for the Case

Teresa Stanek Rea , Crowell & Moring, LLP, Washington, DC, argued for appellant. Also represented by Deborah Yellin.

Jane M. Love , Gibson, Dunn & Crutcher LLP, New York, NY, argued for appellee. Also represented by Robert Trenchard.

Before Lourie, Moore, and Reyna, Circuit Judges.


On February 3, 2017, Apotex Inc. and Apotex Corp. (collectively, Apotex) filed a petition for inter partes review of Novartis Pharmaceuticals Corporation's U.S. Patent No. 9,187,405. The Board instituted proceedings on July 18, 2017, and granted Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries, Inc...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases